Premier sent a letter outlining recommended actions CMS can take immediately to address challenges that long-term care pharmacy (LTCP) and infusion pharmacy providers are facing in the face of the COVID-19 epidemic.
On behalf of LTCP, Premier urged CMS to:
- Provide flexibilities concerning the DRR requirements so that pharmacists and pharmacy personnel may collaborate with facilities on the best methods to continue to provide these required services to residents.
- Provide uniform guidance on Part D point-of-sale edits to override: prior authorizations, formulary interchange, and refill- too-soon requirements.
- Waive the short-cycle dispensing requirements and provide guidance to plans directing them to suspend any policies, practices or procedures that deny coverage based on short-cycle dispensing requirements.
On behalf of home infusion pharmacies, Premier urged CMS to:
- Relax proof of delivery signature requirements for all home infusion drugs.
- Provide proper reimbursement for the services associated with all infusion drugs delivered in the home each day the drug is infused.
About Premier, Inc.
Premier Inc. (NASDAQ: PINC) is a leading healthcare improvement company, uniting an alliance of more than 4,000 U.S. hospitals and health systems and approximately 175,000 other providers and organizations to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost. Premier plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier’s news and investor sites on www.premierinc.com; as well as Twitter, Facebook, LinkedIn, YouTube, Instagram and Premier’s blog for more information about the company.